MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy

Area of Science:

• Nephrology
• Hematology
• Genetics

Background:

• MYH9-related disease is characterized by thrombocytopenia with giant platelets.
• Pathogenic MYH9 mutations may affect at least 1 in 20,000 individuals.
• The disease presents with diverse manifestations, often leading to misdiagnosis.

Purpose of the Study:

• To report on a large series of patients with MYH9 mutations and kidney disease.
• To highlight the diagnostic challenges and clinical variability of MYH9-related disease.
• To emphasize the importance of accurate diagnosis for patient management and genetic counseling.

Main Methods:

• Analysis of a large patient cohort with MYH9 mutations and kidney disease.
• Review of clinical manifestations, including hematological, renal, and extra-renal findings.
• Discussion of diagnostic criteria and potential screening techniques.

Main Results:

• MYH9 mutations are associated with a spectrum of kidney disease, varying in severity and penetrance.
• Common misdiagnoses include idiopathic thrombocytopenic purpura, leading to inappropriate treatments.
• Additional features include deafness, cataracts, and leukocyte inclusions.

Conclusions:

• Accurate diagnosis of MYH9-related kidney disease is essential to prevent harmful interventions.
• Early identification facilitates genetic counseling and appropriate management strategies.
• Morphological analysis of blood cells may enable future high-throughput screening.